Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ultan McDermott

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|October 31, 2014
COSMIC: exploring the world's knowledge of somatic mutations in human cancerSimon A Forbes, David Beare, Prasad Gunasekaran, et al.
Nucleic Acids Research|November 28, 2012
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsWanjuan Yang, Jorge Soares, Patricia Greninger, et al.
Oncotarget|November 6, 2015
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferationKaterina Mardilovich, Mark Baugh, Diane Crighton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263Anahita Dastur, AHyun Choi, Carlotta Costa, et al.
Leukemia|May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemiaTakenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Cancer Research|April 16, 2009
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitorsUltan McDermott, Rachel Y Ames, A John Iafrate, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
Cell|November 27, 2012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingSidong Huang, Michael Hölzel, Theo Knijnenburg, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|October 31, 2014
COSMIC: exploring the world's knowledge of somatic mutations in human cancerSimon A Forbes, David Beare, Prasad Gunasekaran, et al.
Nucleic Acids Research|November 28, 2012
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsWanjuan Yang, Jorge Soares, Patricia Greninger, et al.
Oncotarget|November 6, 2015
LIM kinase inhibitors disrupt mitotic microtubule organization and impair tumor cell proliferationKaterina Mardilovich, Mark Baugh, Diane Crighton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
NOTCH1 Represses MCL-1 Levels in GSI-resistant T-ALL, Making them Susceptible to ABT-263Anahita Dastur, AHyun Choi, Carlotta Costa, et al.
Leukemia|May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemiaTakenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Cancer Research|April 16, 2009
Ligand-dependent platelet-derived growth factor receptor (PDGFR)-alpha activation sensitizes rare lung cancer and sarcoma cells to PDGFR kinase inhibitorsUltan McDermott, Rachel Y Ames, A John Iafrate, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Cancer Discovery|February 23, 2013
Targeting MYCN in neuroblastoma by BET bromodomain inhibitionAlexandre Puissant, Stacey M Frumm, Gabriela Alexe, et al.
Nature Genetics|December 10, 2013
Inactivating CUX1 mutations promote tumorigenesisChi C Wong, Inigo Martincorena, Alistair G Rust, et al.
Cell|November 27, 2012
MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signalingSidong Huang, Michael Hölzel, Theo Knijnenburg, et al.
Pageof 12